FBInvestor
Stocks / Trevi Therapeutics Inc
Institutional Ownership

Trevi Therapeutics Inc

CUSIP 89532M101COMTRVIQ1 2026

Institutional Holders
191
13F filers
Shares Held
128.06M
Aggregate institutional
Institutional Value
$1.53B
Q1 2026
Net New Holders
+10
33 new · 23 closed

Institutional Ownership Trend

Aggregate 13F value by quarter

Multi-quarter trend — upgrade to see history

Upgrade

Position Activity

Q1 2026

New positions33
Increased65
Decreased62
Sold out23

Institutional Holders

191 funds hold this security · Q1 2026

#FundSharesValueΔ SharesActivity
1Nea Management Company, LLC13.22M$157.74M0Held
2Blackrock, Inc.10.24M$122.17M+114.0KAdded
3Frazier Life Sciences Management, L.P.9.94M$118.58M319.9KReduced
4Fmr LLC8.04M$95.89M+1.54MAdded
5Wellington Management Group LLP5.19M$61.91M+1.79MAdded
6Vivo Capital, LLC5.09M$60.78M0Held
7Marshall Wace, LLP3.97M$47.31M614.5KReduced
8Rubric Capital Management LP3.71M$44.29M54.4KReduced
9Mpm Bioimpact LLC3.30M$39.35M+11.3KAdded
10Viking Global Investors LP3.20M$38.16M0Held

181 more institutional holders on Premium

See every fund holding Trevi Therapeutics Inc, with full quarter-over-quarter share changes.

Unlock all holders